Craig L. Duvall
-
Research Snapshot: New drug targets vascular inflammation, drastically improving the long-term effectiveness of vascular procedures
Therapeutic MK2i-NP blocks both inflammation and an unhealthy conversion of cells in blood vessels after cardiovascular procedures, reducing the need for further interventions—cutting costs and reducing risks. Est. reading time: 2.5 minutes. Read MoreOct 11, 2021
-
Research Snapshot: Biomedical engineers demonstrate potential for the first clinically successful osteoarthritis drug
Affecting athletes, military and 25 percent of Americans over 45, Craig Duvall and his team build nanoparticles targeted to mitigate osteoarthritis. Est. reading time: 3.5 mins. Read MoreSep 1, 2021
-
Duvall named Fellow of the Biomedical Engineering Society
Craig Duvall, Cornelius Vanderbilt Professor of Engineering, has been elevated to the rank of Fellow of the Biomedical Engineering Society. Duvall and his research program focus on development of technologies for controlled drug release, tissue regeneration and therapeutics, and delivery of intracellular-acting biologic drugs such as siRNA and peptide therapeutics. The applications of these technologies... Read MoreAug 10, 2020